• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意外诊断为子宫平滑肌肉瘤患者行不完全手术切除后的全子宫切除术再次手术是有帮助的。

Reoperation with Total Hysterectomy after Incomplete Surgery Is Helpful in Patients with Incidentally Diagnosed Uterine Leiomyosarcoma.

机构信息

Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

出版信息

Gynecol Obstet Invest. 2021;86(4):408-414. doi: 10.1159/000515895. Epub 2021 Jul 20.

DOI:10.1159/000515895
PMID:34284401
Abstract

OBJECTIVE

The aim of this study was to evaluate the impact of initial surgical treatments and surgical re-exploration on the oncological outcomes of patients with incidentally diagnosed uterine leiomyosarcoma (uLMS).

DESIGN

A retrospective analysis of 87 patients who underwent re-exploration for incidentally diagnosed uLMS at the Fudan University Shanghai Cancer Center was performed.

METHODS

Kaplan-Meier and Cox proportional hazards regression models were used for analyses.

RESULTS

The median age (range) at diagnosis was 49 (23-76) years. The median disease-free survival (DFS) and overall survival (OS) were 15.1 and 56.7 months, respectively. The Kaplan-Meier curves and log-rank tests showed the median DFS was longer in patients with restaging operation (N = 30) than without (N = 55) (p = 0.017) but no significant difference in median OS (p = 0.142). In patients who underwent myomectomy/subtotal hysterectomy, 5 patients (28.5%) had remnant sarcoma during re-exploration with complete uterine removal, and re-exploration was associated with longer DFS (p = 0.038) and OS (p = 0.042).

LIMITATIONS

The limitation of this study is its retrospective observational design with a limited number of patients.

CONCLUSION

Reoperation with total hysterectomy after incomplete surgery may be helpful in patients with incidentally diagnosed uLMS at the first treatment.

摘要

目的

本研究旨在评估初次手术治疗和再次手术探查对偶然诊断为子宫平滑肌肉瘤(uLMS)患者的肿瘤学结局的影响。

设计

对复旦大学附属肿瘤医院接受再次手术探查的 87 例偶然诊断为 uLMS 的患者进行回顾性分析。

方法

采用 Kaplan-Meier 和 Cox 比例风险回归模型进行分析。

结果

诊断时的中位年龄(范围)为 49(23-76)岁。中位无疾病生存(DFS)和总生存(OS)分别为 15.1 和 56.7 个月。Kaplan-Meier 曲线和对数秩检验显示,再次手术(N=30)患者的中位 DFS 长于未手术(N=55)患者(p=0.017),但中位 OS 无显著差异(p=0.142)。在接受子宫肌瘤切除术/次全子宫切除术的患者中,5 例(28.5%)在再次探查时发现残留肉瘤,且完全子宫切除与更长的 DFS(p=0.038)和 OS(p=0.042)相关。

局限性

本研究的局限性在于其为回顾性观察性设计,患者数量有限。

结论

初次治疗不完全时行全子宫切除术的再次手术可能对偶然诊断为 uLMS 的患者有益。

相似文献

1
Reoperation with Total Hysterectomy after Incomplete Surgery Is Helpful in Patients with Incidentally Diagnosed Uterine Leiomyosarcoma.意外诊断为子宫平滑肌肉瘤患者行不完全手术切除后的全子宫切除术再次手术是有帮助的。
Gynecol Obstet Invest. 2021;86(4):408-414. doi: 10.1159/000515895. Epub 2021 Jul 20.
2
Outcomes of uterine sarcoma found incidentally after uterus-preserving surgery for presumed benign disease.因假定为良性疾病而进行子宫保留手术后偶然发现的子宫肉瘤的结局。
BMC Cancer. 2016 Aug 23;16(1):675. doi: 10.1186/s12885-016-2727-x.
3
The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.无意间分碎的子宫肉瘤患者再次探查的价值。
Gynecol Oncol. 2014 Feb;132(2):360-5. doi: 10.1016/j.ygyno.2013.11.024. Epub 2013 Dec 1.
4
Oncological outcomes of unexpected uterine leiomyosarcoma: A single-center retrospective analysis of 5528 consecutive hysterectomies.意外子宫平滑肌肉瘤的肿瘤学结局:5528 例连续子宫切除术的单中心回顾性分析。
J Surg Oncol. 2024 Mar;129(3):517-522. doi: 10.1002/jso.27509. Epub 2023 Nov 16.
5
The impact of tumor fragmentation in patients with stage I uterine leiomyosarcoma on patterns of recurrence and oncologic outcome.肿瘤碎裂对Ⅰ期子宫平滑肌肉瘤患者复发模式和肿瘤学结局的影响。
Gynecol Oncol. 2021 Jan;160(1):99-105. doi: 10.1016/j.ygyno.2020.10.020. Epub 2020 Nov 4.
6
Prognostic factors and survival outcomes of women with uterine leiomyosarcoma: A Turkish Uterine Sarcoma Group Study-003.土耳其子宫肉瘤研究组 003 号研究:子宫平滑肌肉瘤患者的预后因素和生存结果。
Curr Probl Cancer. 2021 Oct;45(5):100712. doi: 10.1016/j.currproblcancer.2021.100712. Epub 2021 Feb 9.
7
External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma.子宫平滑肌肉瘤患者总生存预后列线图的外部验证。
Cancer. 2013 May 15;119(10):1816-22. doi: 10.1002/cncr.27971. Epub 2013 Mar 1.
8
A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.子宫肉瘤临床特征的多中心回顾性研究
J Obstet Gynaecol Can. 2017 Aug;39(8):652-658. doi: 10.1016/j.jogc.2017.03.090.
9
Secondary cytoreductive surgery in recurrent uterine leiomyosarcoma: a multi-institutional study.复发性子宫平滑肌肉瘤的二次减瘤手术:一项多机构研究
Int J Gynecol Cancer. 2019 Sep;29(7):1134-1140. doi: 10.1136/ijgc-2019-000355. Epub 2019 Aug 15.
10
Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma.I期子宫肉瘤绝经前女性保留卵巢的安全性
J Gynecol Oncol. 2017 Jul;28(4):e46. doi: 10.3802/jgo.2017.28.e46.

引用本文的文献

1
Clinicopathological and survival analysis for patients with uterine sarcoma treated following surgery for presumed benign disease.对接受疑似良性疾病手术后治疗的子宫肉瘤患者的临床病理和生存分析。
BMC Cancer. 2024 Sep 9;24(1):1118. doi: 10.1186/s12885-024-12881-8.
2
Current Treatment Options: Uterine Sarcoma.现行治疗方法:子宫肉瘤。
Curr Treat Options Oncol. 2024 Jul;25(7):829-853. doi: 10.1007/s11864-024-01214-3. Epub 2024 May 31.